Albert Kildani | Vice President of Investor Relations and Corporate Communications |
Helen Torley | President and Chief Executive Officer |
Laurie Stelzer | Chief Financial Officer |
Charles Duncan | Cantor Fitzgerald |
Jim Birchenough | Wells Fargo |
Jason Butler | JMP Securities |
Jessica Fye | JP Morgan |
Joel Beatty | Citi |
Good afternoon everyone. I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics. Mr. Kildani, please begin.
Good afternoon, and welcome to our Third Quarter 2019 Financial Results Conference Call.